NMRA — NEUMORA THERAPEUTICS INC.
As of Q2 2026, 27 SEC-registered investment managers reported holding NMRA (NEUMORA THERAPEUTICS INC.) in their latest 13F filings, with a combined reported value of $39.87M across 23.54M shares. That is +29.8% by share count (+5.41M shares) versus the previous quarter, while reported value moved +12.8%. Ownership is concentrated: the five largest holders account for 74.2% of reported value and the top ten for 91.7%.
Compared with the prior quarter, 6 opened new positions, 12 added to existing stakes, 7 trimmed, 3 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
NMRA is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Hillhouse Capital (HHLR Advisors) history | Q4 2023 | 1.70M | $28.97M | 0.59% | Hold |
| BlackRock Inc history | Q2 2026 | 7.79M | $13.25M | 0.00% | Add |
| Vanguard Group history | Q4 2025 | 4.54M | $8.13M | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 3.50M | $5.95M | 0.00% | Hold |
| Geode Capital Management history | Q2 2026 | 2.61M | $4.43M | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 2.24M | $3.82M | 0.00% | Add |
| Renaissance Technologies history | Q2 2026 | 1.26M | $2.15M | 0.00% | Reduce |
| Citadel Advisors history | Q2 2026 | 1.07M | $1.82M | 0.00% | Add |
| Marshall Wace history | Q2 2026 | 904.46K | $1.54M | 0.00% | Reduce |
| Charles Schwab Investment Management history | Q2 2026 | 823.58K | $1.40M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 800.57K | $1.36M | 0.00% | Add |
| Point72 Asset Management history | Q1 2026 | 602.40K | $1.17M | 0.00% | Reduce |
| Norges Bank Investment Management history | Q4 2024 | 110.00K | $1.17M | 0.00% | Hold |
| Franklin Resources history | Q1 2026 | 511.08K | $996.61K | 0.00% | New |
| Millennium Management history | Q2 2026 | 509.21K | $865.66K | 0.00% | Reduce |
| Morgan Stanley history | Q2 2026 | 319.42K | $543.02K | 0.00% | Reduce |
| Goldman Sachs Group history | Q2 2026 | 303.86K | $516.57K | 0.00% | Reduce |
| BNY Mellon history | Q2 2026 | 247.54K | $420.83K | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 243.19K | $413.43K | 0.00% | Add |
| CPP Investments history | Q2 2026 | 198.40K | $337.28K | 0.00% | Add |
New Positions (Q2 2026)
- Deutsche Bank AG 102.15K sh · $173.65K
- JPMorgan Chase & Co 63.62K sh · $109.43K
- Manulife Financial 26.12K sh · $44.41K
- Prudential Financial 15.47K sh · $26.31K
- Legal & General Investment Management America 9.97K sh · $16.95K
- T. Rowe Price Associates 84.16K sh · $144
Fully Exited (vs previous quarter)
- Point72 Asset Management sold 602.40K sh · $1.17M
- Franklin Resources sold 511.08K sh · $996.61K
- Balyasny Asset Management sold 57.64K sh · $112.40K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | — | — | — | — | 6.19M | 7.11M | 6.35M | 2.88M | 1.82M | 2.02M | 2.05M | 7.79M |
| Fidelity Management & Research (FMR) | 5.62M | 6.37M | 7.48M | 8.62M | 7.75M | 7.84M | 3.50M | 3.50M | 3.50M | 3.50M | 3.50M | 3.50M |
| Geode Capital Management | 122.19K | 436.88K | 452.38K | 1.29M | 1.98M | 1.97M | 1.98M | 916.82K | 968.93K | 1.00M | 1.09M | 2.61M |
| Two Sigma Investments | 58.50K | — | — | 172.52K | 47.60K | 48.29K | 274.31K | 588.33K | 299.81K | 1.31M | 2.04M | 2.24M |
| Renaissance Technologies | — | 13.60K | 138.90K | — | — | — | 1.26M | 1.43M | 1.16M | 1.45M | 1.39M | 1.26M |
| Citadel Advisors | 2.17M | 1.85M | 1.83M | 892.24K | 77.77K | 565.37K | 229.70K | 147.19K | 145.00K | 553.00K | 420.89K | 1.07M |
| Marshall Wace | 256.41K | — | — | 134.54K | — | — | — | 250.49K | — | 583.76K | 1.20M | 904.46K |
| Charles Schwab Investment Management | — | 129.91K | 124.54K | 291.36K | 698.25K | 704.15K | 593.50K | 443.17K | 512.94K | 512.47K | 516.18K | 823.58K |
| Northern Trust Corp | — | 126.44K | 121.39K | 139.64K | 682.38K | 734.85K | 689.25K | 175.40K | 157.81K | 185.36K | 196.88K | 800.57K |
| Millennium Management | 274.75K | — | 136.53K | — | — | 882.43K | 718.33K | 1.23M | 2.01M | 3.62M | 2.75M | 509.21K |
| Morgan Stanley | 400 | 31.08K | 65.38K | 156.74K | 353.69K | 731.41K | 852.37K | 228.64K | 274.77K | 238.48K | 503.82K | 319.42K |
| Goldman Sachs Group | 73.60K | 592.42K | 162.58K | 318.46K | 340.02K | 640.92K | 607.78K | 502.17K | 377.37K | 858.50K | 568.28K | 303.86K |
| BNY Mellon | — | 45.20K | 41.03K | 235.59K | 216.43K | 215.88K | 227.85K | 19.84K | 19.84K | 39.18K | 39.18K | 247.54K |
| Invesco Ltd | — | — | — | 13.45K | 13.91K | 49.25K | 123.66K | 132.04K | 183.80K | 227.59K | 205.93K | 243.19K |
| CPP Investments | — | — | — | — | — | — | — | 55.70K | — | 91.70K | 140.20K | 198.40K |
| UBS Group AG | — | 256 | 25.28K | 295.66K | 339.67K | 1.25M | 3.11M | 650.70K | 129.05K | 94.91K | 59.58K | 143.72K |
| Deutsche Bank AG | — | 8.01K | 8.01K | 36.80K | 48.62K | 73.10K | 67.03K | — | — | — | — | 102.15K |
| Bank of America Corp | — | 15.12K | 22.09K | 60.11K | 66.90K | 105.26K | 869.02K | 71.38K | 137.43K | 102.41K | 176.93K | 100.40K |
| Wells Fargo & Co | — | 27.36K | 34.94K | 58.48K | 57.46K | 70.65K | 45.72K | 6.83K | 5.00K | 10.00K | 5.50K | 98.61K |
| JPMorgan Chase & Co | — | 61.12K | 34.71K | 62.79K | 64.42K | 6.80K | 79.73K | 5.34K | 10.54K | 10.50K | — | 63.62K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details